124 related articles for article (PubMed ID: 38545788)
1. ZIP Code to Genomic Code: Neighborhood Disadvantage, Aggressive Breast Cancer Biology, and Breast Cancer Outcomes.
Goel N; Hernandez AE; Antoni MH; Kesmodel S; Pinheiro PS; Kobetz E; Merchant N; Cole SW
Ann Surg; 2024 Jul; 280(1):1-10. PubMed ID: 38545788
[TBL] [Abstract][Full Text] [Related]
2. Impact of Neighborhood Disadvantage on Tumor Biology and Breast Cancer Survival.
Goel N; Hernandez A; Kwon D; Antoni MH; Cole S
Ann Surg; 2024 Feb; 279(2):346-352. PubMed ID: 37638386
[TBL] [Abstract][Full Text] [Related]
3. IRF-1 inhibits NF-κB activity, suppresses TRAF2 and cIAP1 and induces breast cancer cell specific growth inhibition.
Armstrong MJ; Stang MT; Liu Y; Yan J; Pizzoferrato E; Yim JH
Cancer Biol Ther; 2015; 16(7):1029-41. PubMed ID: 26011589
[TBL] [Abstract][Full Text] [Related]
4. A 6 transcription factors-associated nomogram predicts the recurrence-free survival of thyroid papillary carcinoma.
Wang T; Tian K; Ji X; Song F
Medicine (Baltimore); 2021 Oct; 100(40):e27308. PubMed ID: 34622829
[TBL] [Abstract][Full Text] [Related]
5. Identification of a Transcription Factor Signature That Can Predict Breast Cancer Survival.
Fan C; Du J; Liu N
Comput Math Methods Med; 2021; 2021():2649123. PubMed ID: 33688372
[TBL] [Abstract][Full Text] [Related]
6. Relationship of Oncotype Dx score with tumor grade, size, nodal status, proliferative marker Ki67 and Nottingham Prognostic Index in early breast cancer tumors in Saudi Population.
Durrani S; Al-Mushawa F; Heena H; Wani T; Al-Qahtani A
Ann Diagn Pathol; 2021 Apr; 51():151674. PubMed ID: 33360027
[TBL] [Abstract][Full Text] [Related]
7. Association of Social Determinants and Tumor Biology With Racial Disparity in Survival From Early-Stage, Hormone-Dependent Breast Cancer.
Hoskins KF; Calip GS; Huang HC; Ibraheem A; Danciu OC; Rauscher GH
JAMA Oncol; 2023 Apr; 9(4):536-545. PubMed ID: 36795405
[TBL] [Abstract][Full Text] [Related]
8. Neighborhood Disadvantage and Breast Cancer-Specific Survival.
Goel N; Hernandez A; Thompson C; Choi S; Westrick A; Stoler J; Antoni MH; Rojas K; Kesmodel S; Figueroa ME; Cole S; Merchant N; Kobetz E
JAMA Netw Open; 2023 Apr; 6(4):e238908. PubMed ID: 37083666
[TBL] [Abstract][Full Text] [Related]
9. The association between the expression of nuclear Yes-associated protein 1 (YAP1) and p53 protein expression profile in breast cancer patients.
Cha YJ; Kim D; Bae SJ; Ahn SG; Jeong J; Cho MK; Paik PS; Yoo TK; Park WC; Yoon CI
PLoS One; 2021; 16(5):e0250986. PubMed ID: 33970925
[TBL] [Abstract][Full Text] [Related]
10. Expression of matrix metalloproteinase (MMP)-2 and MMP-9 in breast cancer with a special reference to activator protein-2, HER2, and prognosis.
Pellikainen JM; Ropponen KM; Kataja VV; Kellokoski JK; Eskelinen MJ; Kosma VM
Clin Cancer Res; 2004 Nov; 10(22):7621-8. PubMed ID: 15569994
[TBL] [Abstract][Full Text] [Related]
11. Discordance in 21-gene recurrence scores between paired breast cancer samples is inversely associated with patient age.
Bernhardt SM; Dasari P; Wrin J; Raymond W; Edwards S; Walsh D; Townsend AR; Price TJ; Ingman WV
Breast Cancer Res; 2020 Aug; 22(1):90. PubMed ID: 32811558
[TBL] [Abstract][Full Text] [Related]
12. Establishment and validation of a novel autophagy-related gene signature for patients with breast cancer.
Du JX; Chen C; Luo YH; Cai JL; Cai CZ; Xu J; Ni XJ; Zhu W
Gene; 2020 Dec; 762():144974. PubMed ID: 32707305
[TBL] [Abstract][Full Text] [Related]
13. Reduced nuclear expression of transcription factor AP-2 associates with aggressive breast cancer.
Pellikainen J; Kataja V; Ropponen K; Kellokoski J; Pietiläinen T; Böhm J; Eskelinen M; Kosma VM
Clin Cancer Res; 2002 Nov; 8(11):3487-95. PubMed ID: 12429639
[TBL] [Abstract][Full Text] [Related]
14. High levels of γ-glutamyl hydrolase (GGH) are associated with poor prognosis and unfavorable clinical outcomes in invasive breast cancer.
Shubbar E; Helou K; Kovács A; Nemes S; Hajizadeh S; Enerbäck C; Einbeigi Z
BMC Cancer; 2013 Feb; 13():47. PubMed ID: 23374458
[TBL] [Abstract][Full Text] [Related]
15. Identification of Potential Prognostic Biomarkers for Breast Cancer Based on lncRNA-TF-Associated ceRNA Network and Functional Module.
Li X; Zhu J; Qiu J
Biomed Res Int; 2020; 2020():5257896. PubMed ID: 32802855
[TBL] [Abstract][Full Text] [Related]
16. Lymph Node Status in Breast Cancer Does Not Predict Tumor Biology.
Bello DM; Russell C; McCullough D; Tierno M; Morrow M
Ann Surg Oncol; 2018 Oct; 25(10):2884-2889. PubMed ID: 29968028
[TBL] [Abstract][Full Text] [Related]
17. Amplification and high-level expression of heat shock protein 90 marks aggressive phenotypes of human epidermal growth factor receptor 2 negative breast cancer.
Cheng Q; Chang JT; Geradts J; Neckers LM; Haystead T; Spector NL; Lyerly HK
Breast Cancer Res; 2012 Apr; 14(2):R62. PubMed ID: 22510516
[TBL] [Abstract][Full Text] [Related]
18. Receptor activator of nuclear factor kappa B (RANK) expression in primary breast cancer correlates with recurrence-free survival and development of bone metastases in I-SPY1 (CALGB 150007/150012; ACRIN 6657).
Vidula N; Yau C; Li J; Esserman LJ; Rugo HS
Breast Cancer Res Treat; 2017 Aug; 165(1):129-138. PubMed ID: 28577080
[TBL] [Abstract][Full Text] [Related]
19. Expression of Forkhead-box protein A1, a marker of luminal A type breast cancer, parallels low Oncotype DX 21-gene recurrence scores.
Ademuyiwa FO; Thorat MA; Jain RK; Nakshatri H; Badve S
Mod Pathol; 2010 Feb; 23(2):270-5. PubMed ID: 19946260
[TBL] [Abstract][Full Text] [Related]
20. Neighborhood and Individual Socioeconomic Disadvantage and Survival Among Patients With Nonmetastatic Common Cancers.
Cheng E; Soulos PR; Irwin ML; Cespedes Feliciano EM; Presley CJ; Fuchs CS; Meyerhardt JA; Gross CP
JAMA Netw Open; 2021 Dec; 4(12):e2139593. PubMed ID: 34919133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]